With Pfizer’s stock down sharply, an activist investor is pushing for something new from the CEO who spurred the company to ...
Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...
Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...
Pfizer chief executive Albert Bourla plans to meet Starboard Value, said people familiar with the matter, as the activist ...
Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...
Pfizer CEO is set to meet with activist investor Starboard Value after the investor acquired a $1 billion stake in the ...
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...
Pfizer Inc. CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the ...
Albert Bourla, who four years ago led Pfizer through its scientific and financial triumph during the covid-19 pandemic, is suddenly facing a new challenge from a large shareholder frustrated over ...
Pfizer CEO Albert Bourla plans to meet key executives of activist hedge fund Starboard Value next week, the Financial Times ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback